IRCCS Istituto Tumori "G. Paolo II", 70124 Bari, Italy.
Visby Hospital, Section of Clinical Microbiology and Infectious Diseases, Department of Medical Sciences, 62156 Visby, Sweden.
Medicina (Kaunas). 2022 Sep 11;58(9):1257. doi: 10.3390/medicina58091257.
: Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species (, , , and ) in two healthcare settings located in the Apulia region (Italy). : Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. : In this study, a higher incidence of multi-drug-resistant was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of and were susceptible to linezolid. All the bacterial isolates of and most of were susceptible to ceftazidime-avibactam. Amikacin and nitrofurantoin represented a good option for treating infections. Multidrug-resistant (MDR) , methicillin-resistant (MRSA) and (VRE) had a lower incidence in the clinical setting, with respect to and : The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.
: 抗菌药物耐药性是一个严重的问题,在严重的医院获得性感染(HAI)情况下,可能会危及生命。在过去几十年中,抗生素滥用和多重耐药性(MDR)显著增加了这一负担。本研究的目的是调查意大利普利亚地区(意大利)两个医疗保健环境中五种选定细菌( 、 、 、 和 )的分布和药敏率。: 设置 1 是一家大学医院,设置 2 是一家研究机构,研究对象为肿瘤患者。所有入组患者均被诊断为细菌 HAI。观察期为 2021 年 8 月至 9 月。临床标本来自不同的生物来源,来自不同的医院病房。细菌鉴定和药敏试验采用 VITEC 2 单系统软件进行。: 在这项研究中,与意大利 2019 年的统计报告(30.3%)相比,报告了更高比例的多药耐药 (42.2%在设置 1 中,50%在设置 2 中)。 和 的所有分离株均对利奈唑胺敏感。 和 的所有细菌分离株均对头孢他啶-阿维巴坦敏感。阿米卡星和呋喃妥因是治疗 感染的较好选择。与 和 相比,多药耐药(MDR) 、耐甲氧西林金黄色葡萄球菌(MRSA)和 (VRE)在临床环境中的发生率较低:本研究获得的数据可以为临床医生提供支持,以合理、安全地使用抗生素治疗这些耐药菌株引起的感染,提高当前主要医疗保健环境中使用的抗生素方案的整体疗效。